Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The goal of this clinical trial is to assess the impact of a new care pathway (the Carpal Tunnel Plus Pathway) in patients with carpal tunnel syndrome. The main questions it aims to answer are:
Researchers will compare wait times pre- and post- Pathway implementation to see if there was any change.
Participants will be asked to complete a short patient satisfaction survey.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Retrospective (Pre-Intervention) | Participants in this arm were treated for carpal tunnel syndrome before the Carpal Tunnel Plus Pathway was implemented. | ||
| Prospective (Post-Intervention) | Participants in this arm were treated for carpal tunnel syndrome after the Carpal Tunnel Plus Pathway was implemented. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Changes to the care pathway for carpal tunnel syndrome (The Carpal Tunnel Plus Pathway) | Procedure | Changes to the care pathway for carpal tunnel syndrome. Features of the CTS+ pathway include new referral form, care map for mild, moderate and severe CTS established, point or care ultrasound with steroid injection introduced, and expedited referral to surgeons. |
| Measure | Description | Time Frame |
|---|---|---|
| Wait times | Time between each step of the care pathway (e.g. from referral to EMG/neurologic consultation, from referral to surgical consultation, from surgical consultation to surgery) | From initial referral to surgery/injection (variable, but approximately 9 months) |
| Patient satisfaction | Patients will be asked to complete a short questionnaire to indicate their level of satisfaction with the care that they received. The custom survey will consist of 4 questions on various aspects of their care that participants will rate on a scale of 1-5 (1 = not at all satisfied, 5 = very satisfied). | Immediately after surgery/injection appointment |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Retrospective: Patients age 18 or over seen by study surgeons for CTS. Prospective: patients age 18 or over with carpal tunnel syndrome seen at SPH or Vancouver Hospital EMG lab.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Kristine Chapman | University of British Columbia | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Vancouver General Hospital | Vancouver | British Columbia | V5Z 1M9 | Canada |
Not provided
| Label | URL |
|---|---|
| Website for the Carpal Tunnel Plus Pathway | View source |
Not provided
Individual participant data will not be shared. Only group averages/summary measures will be included in any publications.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D002349 | Carpal Tunnel Syndrome |
| D017060 | Patient Satisfaction |
| ID | Term |
|---|---|
| D020423 | Median Neuropathy |
| D020422 | Mononeuropathies |
| D010523 | Peripheral Nervous System Diseases |
| D009468 | Neuromuscular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
|
| D009422 | Nervous System Diseases |
| D009408 | Nerve Compression Syndromes |
| D012090 | Cumulative Trauma Disorders |
| D013180 | Sprains and Strains |
| D014947 | Wounds and Injuries |
| D000074822 | Treatment Adherence and Compliance |
| D015438 | Health Behavior |
| D001519 | Behavior |